Change in biopharma outsourcing model usage 2021 vs. 2023
According to a survey conducted in 2023, over 40 percent of surveyed biopharma executives stated that the usage of the functional service provider (FSP) outsourcing model has increased compared to two years ago. This statistic describes the change in full-service and FSP outsourcing models among biopharmaceutical companies worldwide in 2021-2023.